Loading...
NPI 1467891952 · Providence, RI · Retina Specialist (Ophthalmology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Brian Savoie is a retina specialist (ophthalmology) physician provider located in Providence, Rhode Island. This profile covers 13 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Brian Savoie |
| Address | 120 Dudley St Ste 303 |
| City | Providence |
| State | RI |
| ZIP | 02905 |
| Taxonomy | Retina Specialist (Ophthalmology) Physician |
| NPI Enumerated | June 18, 2013 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.4M |
| Medicaid | $55.1K |
Practice is procedure-centric and aligned with retina specialty care: the top Medicare and Medicaid revenue drivers are intravitreal injection drugs and injection procedures (J0178, J2777, 67028), supported by retinal imaging (92134). This mix — high-volume anti-VEGF administration and retinal diagnostic imaging — is consistent with a retina specialist model focused on ongoing injection therapy and follow-up imaging rather than primary general ophthalmology visits.
Medicare revenue is highly concentrated: the precomputed top 3 Medicare codes (J0178, J2777, 67028) account for 90.3% of this provider's Medicare revenue, led by J0178 at $1M (72.3% of Medicare revenue) and followed by J2777 at $170.5K (11.9%) and 67028 at $87.1K (6.1%). That concentration indicates the provider’s Medicare business is dominated by a small set of injection-related services and associated procedures.
Medicaid billing is even more concentrated within three codes: the precomputed top 3 Medicaid codes (67028, 92134, 99213) account for 100.0% of Medicaid revenue, with 67028 contributing $37.3K (67.7%) and 92134 contributing $15.3K (27.8%). This shows the provider’s Medicaid activity mirrors Medicare in focusing on injection procedures and retinal imaging, with minimal other Medicaid-reimbursed services.
Scale and payer mix are strongly weighted to Medicare: lifetime Medicare revenue is $1.4M versus $55.1K in Medicaid, indicating the provider operates at Medicare scale and is effectively Medicare-dominant in payer mix. Medicaid represents a small fraction of total reported lifetime revenue, so Medicaid market position has limited impact on overall revenue stability.
Competitive standing on key Medicare procedure volumes is mixed: J0178 ranks #826 of 3204 providers nationally (74th percentile) and is described as a typical, unremarkable volume for the code, so the provider is a solid but not leading national participant for aflibercept injections. By contrast, retinal imaging 92134 ranks #1566 of 26868 providers (94th percentile) and is labeled notably above typical national volume, indicating comparatively strong activity in diagnostic imaging relative to national peers despite its smaller share of revenue.
Evaluation-and-management (E/M) patterns differ by payer: Medicare 99213 shows high relative volume (540 claims, $37.3K, rank #23574 of 457151, 95th percentile, described as notably above typical national volume), suggesting frequent established-patient encounters in Medicare. In Medicaid the same code (99213) is modest (54 claims, $2.5K, rank #1577 of 2046, 23rd percentile), indicating E/M services are much more Medicare-weighted within this provider’s practice.
State-level competitive position for Medicaid is modest: the top Medicaid injection code 67028 ranks #9 of 14 in-state (38th percentile) and 92134 ranks #10 of 24 (61st percentile), both characterized as typical/unremarkable volumes in-state. These ranks imply the provider is an active but not dominant Medicaid retina provider within Rhode Island.
Tenure supports an established practice footprint: the provider’s NPI was enumerated on 2013-06-18 (~13 years ago), consistent with a stable, mid-tenure retina practice that has built a concentrated injection-and-imaging revenue base over time. This duration aligns with sustained procedural patterns observed in both Medicare and Medicaid billing.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 1,500 | $690 | $1M |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 5,880 | $30 | $170.5K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 910 | $100 | $87.1K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,460 | $30 | $46.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 540 | $70 | $37.3K |
| J2778 | Injection, ranibizumab, 0.1 mg | 170 | $150 | $25.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 90 | $100 | $8.6K |
| J9035 | Injection, bevacizumab, 10 mg | 160 | $50 | $8.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 60 | $130 | $7.5K |
| 92235 | The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken… | 20 | $110 | $2.1K |
Showing 1–10 of 13
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
13 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 4 | 10 | 670 | $690 | $601.6K |
| J2777 | 3 | 10 | 5,790 | $30 | $158K |
| J2778 | 4 | 10 | 460 | $180 | $78.7K |
| 67028 | 5 | 20 | 610 | $90 | $58.9K |
| 99214 | 1,010 | 1,950 | 100 | $80 | $11.7K |
| J9035 | 8 | 20 | 160 | $50 | $9.5K |
| 99213 | 58 | 1,950 | 70 | $60 | $7.4K |
| 92134 | 6 | 120 | 50 | $30 | $6.6K |
| 99204 | 131 | 740 | 30 | $110 | $4.6K |
| 92235 | 7 | 10 | 20 | $100 | $3.6K |
Showing 1–10 of 13
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 120 | $320 | $37.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 730 | $20 | $15.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 50 | $50 | $2.5K |
How this provider's Medicaid billing volume and revenue compare to other Rhode Island providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Rhode Island median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 9 | 10 | 170 | $230 | $144.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,577 | 2,050 | 300 | $50 | $72.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 10 | 20 | 560 | $50 | $61.6K |
Other providers in the same ZIP code as Brian Savoie, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.